We are a service provider for the development, validation and support of ultra sensitive and technically demanding immunoassays for quantifying large molecule targets in virtually any biological matrix. We have expertise and technical capabilities to identify the ideal platform technology based on and run according to your pharmacological and regulatory requirements.
Chimera Biotec provides ultra sensitive GLP/GCP bioanalytical support for all phases of drug discovery and development. For over 15 years, we have specialized in supporting drug development programs with highest demands on bioanalytical quality. Our long standing know how in beyond ELISA sensitive immunoassays enables us to make the most out of any immunoassay platform.
Building on our proprietary award-winning Immuno-PCR based platform, Imperacer®, we offer services on several immunoassay platforms and are always on the lookout for innovative instrumentation. We have the technical capabilities and the veteran insight to define the optimal platform technology for your study based on your pharmacological requirements.